NVS · Novartis
AI read · Good for NVS
The AI's read
Faster discovery could help Novartis move more research ideas toward testing. AI is also helping the company choose targets, including kidney-disease targets. The report does not say any AI-found drug has succeeded in trials or brought in added sales, so the benefit is promising but not yet proven in patients or income.